News Focus
News Focus
Followers 968
Posts 387456
Boards Moderated 0
Alias Born 06/24/2011

Re: None

Wednesday, 07/02/2025 7:38:49 AM

Wednesday, July 02, 2025 7:38:49 AM

Post# of 159
"Despite decades of use, warfarin has significant limitations – especially in complex patients with LVADs," said Quang X. Pham, Chairman and CEO of Cadrenal Therapeutics. "This research reinforces our conviction that tecarfarin has the potential to transform anticoagulation management for this high-risk population who currently has no alternative options." https://finance.yahoo.com/news/cadrenal-therapeutics-highlights-research-anticoagulation-120000058.html $CVKD
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVKD News